JP2008513498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008513498A5 JP2008513498A5 JP2007532629A JP2007532629A JP2008513498A5 JP 2008513498 A5 JP2008513498 A5 JP 2008513498A5 JP 2007532629 A JP2007532629 A JP 2007532629A JP 2007532629 A JP2007532629 A JP 2007532629A JP 2008513498 A5 JP2008513498 A5 JP 2008513498A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- group
- independently selected
- rings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 74
- 239000001257 hydrogen Substances 0.000 claims 74
- 125000000217 alkyl group Chemical group 0.000 claims 53
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 46
- 125000003118 aryl group Chemical group 0.000 claims 40
- 125000000753 cycloalkyl group Chemical group 0.000 claims 40
- 125000001072 heteroaryl group Chemical group 0.000 claims 40
- 125000000623 heterocyclic group Chemical group 0.000 claims 40
- 125000003710 aryl alkyl group Chemical group 0.000 claims 33
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 33
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 28
- 150000002431 hydrogen Chemical class 0.000 claims 28
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 22
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 22
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 22
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 22
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 22
- 125000003367 polycyclic group Chemical group 0.000 claims 18
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 16
- 125000001309 chloro group Chemical group Cl* 0.000 claims 16
- 125000001153 fluoro group Chemical group F* 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 125000004043 oxo group Chemical group O=* 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 8
- 239000000651 prodrug Substances 0.000 claims 8
- 229940002612 prodrug Drugs 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 101000631826 Homo sapiens Stearoyl-CoA desaturase Proteins 0.000 claims 6
- 102000055981 human SCD1 Human genes 0.000 claims 6
- 108010087894 Fatty acid desaturases Proteins 0.000 claims 4
- 102000016553 Stearoyl-CoA Desaturase Human genes 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- 208000004930 Fatty Liver Diseases 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000010706 fatty liver disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 2
- WFNHQQPAILHHHY-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-(3-methylbutyl)imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCC(C)C)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F WFNHQQPAILHHHY-UHFFFAOYSA-N 0.000 claims 1
- IJUINEMMNVBKSC-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-hexylimidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F IJUINEMMNVBKSC-UHFFFAOYSA-N 0.000 claims 1
- CQKHBKHSSXUYNW-UHFFFAOYSA-N 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-n-pentylimidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC(F)=CC=C1C(F)(F)F CQKHBKHSSXUYNW-UHFFFAOYSA-N 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- CHANIKOYXKLUJA-UHFFFAOYSA-N [4-(2-butylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F CHANIKOYXKLUJA-UHFFFAOYSA-N 0.000 claims 1
- PZGGHBAFDRRBJC-UHFFFAOYSA-N [4-(2-ethylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F PZGGHBAFDRRBJC-UHFFFAOYSA-N 0.000 claims 1
- UWEIAULOMZAVFL-UHFFFAOYSA-N [4-(2-pentyl-3h-benzimidazol-5-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C=1C=C2NC(CCCCC)=NC2=CC=1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F UWEIAULOMZAVFL-UHFFFAOYSA-N 0.000 claims 1
- AECMFRRWQZBFCY-UHFFFAOYSA-N [4-(2-pentylimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C1=CC2=NC(CCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F AECMFRRWQZBFCY-UHFFFAOYSA-N 0.000 claims 1
- UKFUGRVXZDKAHC-UHFFFAOYSA-N [4-(2-propyl-3h-benzimidazol-5-yl)piperazin-1-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound C=1C=C2NC(CCC)=NC2=CC=1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F UKFUGRVXZDKAHC-UHFFFAOYSA-N 0.000 claims 1
- UXIXHNZAEPVELV-UHFFFAOYSA-N butanamide 6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid Chemical compound C(CCC)(=O)N.FC(C1=C(C(=O)N2CCN(CC2)C=2C=CC=3N(N2)C=C(N3)C(=O)O)C=CC=C1)(F)F UXIXHNZAEPVELV-UHFFFAOYSA-N 0.000 claims 1
- QRRCXKJNOUZZDS-UHFFFAOYSA-N butanamide 6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid Chemical compound C(CCC)(=O)N.FC=1C=CC(=C(C(=O)N2CCN(CC2)C=2C=CC=3N(N2)C=C(N3)C(=O)O)C1)C(F)(F)F QRRCXKJNOUZZDS-UHFFFAOYSA-N 0.000 claims 1
- LAFZMBWMUSXBPY-UHFFFAOYSA-N n-(3-cyclopropylpropyl)-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound FC1=CC=C(C(F)(F)F)C(C(=O)N2CCN(CC2)C2=NN3C=C(N=C3C=C2)C(=O)NCCCC2CC2)=C1 LAFZMBWMUSXBPY-UHFFFAOYSA-N 0.000 claims 1
- QNWVQJMOJXPWFC-UHFFFAOYSA-N n-(4-fluorophenyl)-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1NC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=CC=3)C(F)(F)F)C2=N1 QNWVQJMOJXPWFC-UHFFFAOYSA-N 0.000 claims 1
- PMFPUIKGZQZPBB-UHFFFAOYSA-N n-(5-chloropyridin-2-yl)-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N1CCN(C2=NN3C=C(N=C3C=C2)C(=O)NC=2N=CC(Cl)=CC=2)CC1 PMFPUIKGZQZPBB-UHFFFAOYSA-N 0.000 claims 1
- RWGDYMLWUNTSIJ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=CC=3)C(F)(F)F)C2=N1 RWGDYMLWUNTSIJ-UHFFFAOYSA-N 0.000 claims 1
- SHBVWULGQNELRK-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=C(F)C=3)C(F)(F)F)C2=N1 SHBVWULGQNELRK-UHFFFAOYSA-N 0.000 claims 1
- IPPLKHPXLPDXSZ-UHFFFAOYSA-N n-[2-(4-fluorophenyl)ethyl]-6-[4-[5-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC(F)=CC=C1CCNC(=O)C1=CN(N=C(C=C2)N3CCN(CC3)C(=O)C=3C(=CC=C(F)C=3)C(F)(F)F)C2=N1 IPPLKHPXLPDXSZ-UHFFFAOYSA-N 0.000 claims 1
- HLNLHSIUBXRMAW-UHFFFAOYSA-N n-pentyl-6-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxamide Chemical compound C1=CC2=NC(C(=O)NCCCCC)=CN2N=C1N(CC1)CCN1C(=O)C1=CC=CC=C1C(F)(F)F HLNLHSIUBXRMAW-UHFFFAOYSA-N 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 0 CCNC(C(C)C(C)(C(*)C(*)(*)CCC(C)(*)C(C)C)*=C)C1CCCCC1 Chemical compound CCNC(C(C)C(C)(C(*)C(*)(*)CCC(C)(*)C(C)C)*=C)C1CCCCC1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61164604P | 2004-09-20 | 2004-09-20 | |
| US60/611,646 | 2004-09-20 | ||
| PCT/US2005/033738 WO2006034312A1 (en) | 2004-09-20 | 2005-09-20 | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133967A Division JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008513498A JP2008513498A (ja) | 2008-05-01 |
| JP2008513498A5 true JP2008513498A5 (https=) | 2008-10-30 |
| JP5080256B2 JP5080256B2 (ja) | 2012-11-21 |
Family
ID=35623357
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532629A Expired - Fee Related JP5080256B2 (ja) | 2004-09-20 | 2005-09-20 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
| JP2012133967A Withdrawn JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133967A Withdrawn JP2012193188A (ja) | 2004-09-20 | 2012-06-13 | 二環式複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼ（ＳＣＤ）のインヒビターとしてのそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7547698B2 (https=) |
| EP (1) | EP1804792A1 (https=) |
| JP (2) | JP5080256B2 (https=) |
| CN (1) | CN101083986A (https=) |
| AR (1) | AR051294A1 (https=) |
| AU (1) | AU2005286790A1 (https=) |
| BR (1) | BRPI0515477A (https=) |
| CA (1) | CA2580781A1 (https=) |
| MX (1) | MX2007003329A (https=) |
| TW (1) | TW200626148A (https=) |
| WO (1) | WO2006034312A1 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| MX2007003318A (es) | 2004-09-20 | 2007-05-18 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
| AU2005286647A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| AU2005286728A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| BRPI0515500A (pt) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
| CN101084211A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| BRPI0515482A (pt) * | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| EP1827438B2 (en) * | 2004-09-20 | 2014-12-10 | Xenon Pharmaceuticals Inc. | Piperazin derivatives for inhibiting human stearoyl-coa-desaturase |
| MX2007003332A (es) * | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa. |
| CA2585172C (en) | 2004-10-29 | 2014-08-12 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| CA2618646A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| CA2610196A1 (en) * | 2005-06-09 | 2006-12-14 | Merck Frosst Canada Ltd. | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| HUE040020T2 (hu) | 2005-10-25 | 2019-02-28 | Kalypsys Inc | PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére |
| EP1966183A4 (en) | 2005-12-20 | 2010-12-29 | Merck Frosst Canada Ltd | HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A-DELTA-9-DESATURASE |
| WO2007143597A2 (en) | 2006-06-05 | 2007-12-13 | Novartis Ag | Organic compounds |
| MX2009002019A (es) | 2006-08-24 | 2009-03-09 | Novartis Ag | Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros. |
| WO2008044767A1 (en) * | 2006-10-13 | 2008-04-17 | Takeda Pharmaceutical Company Limited | Aromatic amine derivative and use thereof |
| TW200826936A (en) | 2006-12-01 | 2008-07-01 | Merck Frosst Canada Ltd | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
| US8575167B2 (en) | 2007-02-06 | 2013-11-05 | Takeda Pharmaceutical Company Limited | Spiro compounds having stearoyl-CoA desaturase action |
| CA2687338A1 (en) * | 2007-05-23 | 2008-11-27 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| WO2008157844A1 (en) | 2007-06-21 | 2008-12-24 | Forest Laboratories Holdings Limited | Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| EP2178877A1 (en) * | 2007-07-13 | 2010-04-28 | GlaxoSmithKline LLC | Anti-viral compounds, compositions, and methods of use |
| CA2693290A1 (en) * | 2007-07-20 | 2009-01-29 | Merck Frosst Canada Ltd. | Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| WO2009124259A1 (en) * | 2008-04-04 | 2009-10-08 | Cv Therapeutics, Inc. | Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| BRPI0910987A2 (pt) | 2008-04-04 | 2017-03-21 | Gilead Sciences Inc | derivados de triazolopiridinona para uso como inibidores de estearoil-coa dessaturase |
| EP2398809B1 (en) | 2009-02-17 | 2015-07-08 | Merck Canada Inc. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| EP2459568A4 (en) | 2009-07-28 | 2013-02-27 | Merck Frosst Canada Ltd | NEW SPIRO COMPOUNDS AS AN INHIBITORS OF STEAROYL COENZYME A DELTA 9 DESATURASE |
| EP2475367A1 (en) | 2009-09-10 | 2012-07-18 | Centre National De La Recherche Scientifique | NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| JP5541454B2 (ja) * | 2009-09-16 | 2014-07-09 | Ｊｓｒ株式会社 | 液晶配向剤および液晶表示素子 |
| US8940716B2 (en) | 2010-05-06 | 2015-01-27 | Bristol-Myers Squibb Company | Bicyclic heteroaryl compounds as GPR119 modulators |
| WO2011153359A1 (en) | 2010-06-04 | 2011-12-08 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| CA2803923A1 (en) | 2010-06-25 | 2011-12-29 | Ignacio R. Rodriguez | Methods of treatment using sterculic acid |
| US9358250B2 (en) | 2011-10-15 | 2016-06-07 | Genentech, Inc. | Methods of using SCD1 antagonists |
| US9233102B2 (en) | 2012-03-07 | 2016-01-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| MX2014014174A (es) | 2012-05-22 | 2015-07-06 | Hoffmann La Roche | Inhibidores selectivos de celulas no diferenciadas. |
| KR20150090100A (ko) * | 2012-12-03 | 2015-08-05 | 에프. 호프만-라 로슈 아게 | 스테아로일-CoA 불포화화효소 1(에스씨디 1)의 억제제로서의 치환된 이속사졸 아마이드 화합물 |
| BR112015019276A2 (pt) | 2013-02-19 | 2017-07-18 | Pfizer | compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios |
| WO2016012896A1 (en) | 2014-07-24 | 2016-01-28 | Pfizer Inc. | Pyrazolopyrimidine compounds |
| MD20170011A2 (ro) | 2014-08-06 | 2017-08-31 | Pfizer Inc. | Compuşi imidazopiridazinici |
| WO2016022955A1 (en) | 2014-08-07 | 2016-02-11 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| JP2019533022A (ja) | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス，インコーポレーテッド | 化合物及びその使用 |
| EP3566055B1 (en) | 2017-01-06 | 2025-03-12 | Janssen Pharmaceutica NV | Scd inhibitor for the treatment of neurological disorders |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| WO2019183587A1 (en) | 2018-03-23 | 2019-09-26 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| WO2020154571A1 (en) | 2019-01-24 | 2020-07-30 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| KR20230015404A (ko) * | 2020-05-22 | 2023-01-31 | 반더빌트유니버시티 | 무스카린성 아세틸콜린 수용체 m5의 경쟁적 억제제 및 비경쟁적 억제제 |
Family Cites Families (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
| US3830924A (en) * | 1966-12-23 | 1974-08-20 | American Cyanamid Co | Substituted nitroimidazolyl-thiadiazoles as growth promoting agents |
| GB1290145A (https=) * | 1969-01-21 | 1972-09-20 | ||
| AT340933B (de) * | 1973-08-20 | 1978-01-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze |
| DE2516040C2 (de) * | 1974-06-10 | 1984-12-20 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US4247551A (en) * | 1979-09-17 | 1981-01-27 | Gruppo Lepetit S.P.A. | N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents |
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| CH653021A5 (fr) * | 1981-04-24 | 1985-12-13 | Delalande Sa | Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant. |
| DE3139970A1 (de) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| US4439606A (en) * | 1982-05-06 | 1984-03-27 | American Cyanamid Company | Antiatherosclerotic 1-piperazinecarbonyl compounds |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| DE3827599A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Verwendung von optisch aktiven tetrahydrofuran-2-carbonsaeureestern als dotierstoffe in fluessigkristallmischungen, diese enthaltende fluessigkristallmischungen und neue optisch aktive tetrahydrofuran-2-carbonsaeureester |
| EP0471201A1 (de) * | 1990-07-21 | 1992-02-19 | Hoechst Aktiengesellschaft | Neue Oxazolidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| EP0520292A1 (de) * | 1991-06-19 | 1992-12-30 | Hoechst Aktiengesellschaft | Chirale Azetidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen |
| EP0524146A1 (de) * | 1991-07-19 | 1993-01-20 | Ciba-Geigy Ag | Aminosubstituierte Piperazinderivate |
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| JPH05345780A (ja) * | 1991-12-24 | 1993-12-27 | Kumiai Chem Ind Co Ltd | ピリミジンまたはトリアジン誘導体及び除草剤 |
| DE4236106A1 (de) * | 1992-10-26 | 1994-04-28 | Hoechst Ag | Azaaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssigkristallinen Mischungen |
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| US5380726A (en) * | 1993-01-15 | 1995-01-10 | Ciba-Geigy Corporation | Substituted dialkylthio ethers |
| US5547605A (en) * | 1993-12-15 | 1996-08-20 | Hoechst Aktiengesellschaft | 2-Aryloxytetrafluoropropionic esters, process for their preparation, and their use in liquid-crystalline mixtures |
| US5571811A (en) * | 1994-07-12 | 1996-11-05 | Janssen Pharmaceutica N.V. | Sulfonamide derivatives of azolones |
| US5637592A (en) * | 1994-07-12 | 1997-06-10 | Janssen Pharmaceutica N.V. | Acyl derivatives of azolones |
| US5668148A (en) * | 1995-04-20 | 1997-09-16 | Merck & Co., Inc. | Alpha1a adrenergic receptor antagonists |
| DE19517056A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-5,6,7,8-tetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517051A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluor-6,7-dihydro-5H-isochinolin-8-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517025A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | Trifluortetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517060A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1-Fluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| DE19517038A1 (de) * | 1995-05-10 | 1996-11-14 | Hoechst Ag | 1,8-Difluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen |
| ZA969622B (en) * | 1995-12-13 | 1998-05-15 | Upjohn Co | Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring. |
| US6251911B1 (en) * | 1996-10-02 | 2001-06-26 | Novartis Ag | Pyrimidine derivatives and processes for the preparation thereof |
| DE59707681D1 (de) * | 1996-10-28 | 2002-08-14 | Rolic Ag Zug | Vernetzbare, photoaktive Silanderivate |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| WO1999054305A1 (de) * | 1998-04-20 | 1999-10-28 | Basf Aktiengesellschaft | Heterocyclisch substituierte amide als calpainhemmer |
| AU5574799A (en) * | 1998-08-25 | 2000-03-14 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| CN1329614A (zh) | 1998-10-21 | 2002-01-02 | 武田药品工业株式会社 | 稠合的哒嗪衍生物、它们的制备方法和用途 |
| FR2792314B1 (fr) * | 1999-04-15 | 2001-06-01 | Adir | Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9912413D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| US6127382A (en) * | 1999-08-16 | 2000-10-03 | Allergan Sales, Inc. | Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| US6677452B1 (en) * | 1999-09-30 | 2004-01-13 | Lion Bioscience Ag | Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof |
| WO2001062954A2 (en) * | 2000-02-24 | 2001-08-30 | Xenon Genetics, Inc. | Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| DE60130771T2 (de) * | 2000-07-27 | 2008-07-17 | Eli Lilly And Co., Indianapolis | Substituierte heterocyclische amide |
| EP1309594B1 (fr) * | 2000-08-08 | 2004-12-15 | Sanofi-Aventis | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| US6738895B1 (en) * | 2000-08-31 | 2004-05-18 | Micron Technology, Inc. | Method and system for substantially registerless processing |
| ATE402262T1 (de) | 2000-09-26 | 2008-08-15 | Xenon Pharmaceuticals Inc | Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden |
| FR2815032B1 (fr) * | 2000-10-10 | 2003-08-08 | Pf Medicament | Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations |
| DE10060412A1 (de) * | 2000-12-05 | 2002-06-06 | Bayer Ag | DELTA1-Pyrroline |
| KR20030082990A (ko) * | 2001-03-15 | 2003-10-23 | 아스트라제네카 아베 | 메탈로프로테이나제 억제제 |
| FR2823209B1 (fr) * | 2001-04-04 | 2003-12-12 | Fournier Lab Sa | Nouvelles thiohydantoines et leur utilisation en therapeutique |
| US6911447B2 (en) * | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
| DE60230266D1 (de) * | 2001-06-15 | 2009-01-22 | Astellas Pharma Inc | Phenylpyridincarbonyl piperazinderivate |
| US7064215B2 (en) * | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
| US7115607B2 (en) * | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| FR2829926B1 (fr) * | 2001-09-26 | 2004-10-01 | Oreal | Composition pour la teinture des fibres keratiniques comprenant un colorant diazoique dicationique particulier |
| US6916812B2 (en) * | 2001-10-09 | 2005-07-12 | Bristol-Myers Squibb Company | Alpha-aminoamide derivatives as melanocortin agonists |
| US6824707B2 (en) * | 2001-10-23 | 2004-11-30 | Clariant International Ltd. | Active matrix liquid crystal device and smectic liquid crystal mixture |
| EP1452525A4 (en) * | 2001-10-30 | 2005-01-26 | Nippon Shinyaku Co Ltd | AMIDE DERIVATIVES AND CORRESPONDING MEDICAMENTS |
| GB0127008D0 (en) | 2001-11-09 | 2002-01-02 | Novartis Ag | Organic compounds |
| US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| FR2833261B1 (fr) * | 2001-12-06 | 2004-07-02 | Yang Ji Chemical Company Ltd | Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii |
| US7390813B1 (en) * | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| US20030166932A1 (en) * | 2002-01-04 | 2003-09-04 | Beard Richard L. | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| EP1474401A2 (en) | 2002-02-05 | 2004-11-10 | Novo Nordisk A/S | Novel aryl- and heteroarylpiperazines |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| JP2005289816A (ja) * | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| PL377215A1 (pl) | 2002-10-17 | 2006-01-23 | Amgen Inc. | Pochodne benzimidazolu oraz ich zastosowanie w charakterze ligandów receptora waniloidowego |
| US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| DE10259382A1 (de) * | 2002-12-18 | 2004-07-01 | Abbott Gmbh & Co. Kg | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung |
| US20050130989A1 (en) * | 2003-01-28 | 2005-06-16 | Aventis Pharma S. A. | N-arylheteroaromatic products compositions containing them and use thereof |
| US6861422B2 (en) * | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| PE20050226A1 (es) * | 2003-06-04 | 2005-05-18 | Aventis Pharma Sa | Productos aril-heteroaromaticos y composiciones que los contienen |
| AU2004257025B9 (en) * | 2003-06-27 | 2010-05-27 | Msd K.K. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| FR2857966A1 (fr) * | 2003-07-24 | 2005-01-28 | Aventis Pharma Sa | Produits aryl-heteroaromatiques, compositions les contenant et utilisation |
| MXPA06001202A (es) * | 2003-07-29 | 2006-08-31 | Xenon Pharmaceuticals Inc | Derivados piridilo y su uso como agentes terapeuticos. |
| PL1648874T3 (pl) * | 2003-07-30 | 2012-04-30 | Xenon Pharmaceuticals Inc | Pochodne piperazyny i ich zastosowanie jako środków leczniczych |
| US7456180B2 (en) | 2003-07-30 | 2008-11-25 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their use as therapeutic agents |
| US7754711B2 (en) * | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| RS53252B (sr) * | 2003-08-11 | 2014-08-29 | F.Hoffmann-La Roche Ag. | Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1 |
| EP1659123A1 (en) * | 2003-08-29 | 2006-05-24 | Dainippon Sumitomo Pharma Co., Ltd. | Bicyclic pyrazole derivative |
| WO2005023261A1 (en) * | 2003-09-09 | 2005-03-17 | F. Hoffmann-La Roche Ag | 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| US20050124660A1 (en) * | 2003-10-27 | 2005-06-09 | Jochen Antel | Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds |
| US7345043B2 (en) * | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| AR048523A1 (es) * | 2004-04-07 | 2006-05-03 | Kalypsys Inc | Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos |
| FR2868780B1 (fr) * | 2004-04-13 | 2008-10-17 | Sanofi Synthelabo | Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique |
| AU2005286728A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| MX2007003332A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa. |
| BRPI0515500A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados piridazina para inibição de estearoil-coa-desaturase |
| EP1827438B2 (en) * | 2004-09-20 | 2014-12-10 | Xenon Pharmaceuticals Inc. | Piperazin derivatives for inhibiting human stearoyl-coa-desaturase |
| CN101084211A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为治疗剂的用途 |
| BRPI0515482A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| MX2007003318A (es) | 2004-09-20 | 2007-05-18 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
| AU2005286647A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| BRPI0519794A2 (pt) * | 2005-01-07 | 2009-03-17 | Hoffmann La Roche | derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos |
| CA2618646A1 (en) * | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| CA2681560A1 (en) * | 2007-04-09 | 2008-10-16 | Cv Therapeutics, Inc. | Pteridinone derivatives for use as stearoyl coa desaturase inhibitors |
| UA100192C2 (en) * | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
-
2005
- 2005-09-20 AU AU2005286790A patent/AU2005286790A1/en not_active Abandoned
- 2005-09-20 CA CA002580781A patent/CA2580781A1/en not_active Abandoned
- 2005-09-20 US US11/575,643 patent/US7547698B2/en not_active Expired - Fee Related
- 2005-09-20 BR BRPI0515477-4A patent/BRPI0515477A/pt not_active IP Right Cessation
- 2005-09-20 AR ARP050103902A patent/AR051294A1/es unknown
- 2005-09-20 CN CNA2005800396667A patent/CN101083986A/zh active Pending
- 2005-09-20 WO PCT/US2005/033738 patent/WO2006034312A1/en not_active Ceased
- 2005-09-20 EP EP05808906A patent/EP1804792A1/en not_active Withdrawn
- 2005-09-20 MX MX2007003329A patent/MX2007003329A/es unknown
- 2005-09-20 TW TW094132549A patent/TW200626148A/zh unknown
- 2005-09-20 JP JP2007532629A patent/JP5080256B2/ja not_active Expired - Fee Related
-
2009
- 2009-05-06 US US12/436,665 patent/US20110009414A9/en not_active Abandoned
-
2012
- 2012-06-13 JP JP2012133967A patent/JP2012193188A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513498A5 (https=) | ||
| JP2008513506A5 (https=) | ||
| JP2008513516A5 (https=) | ||
| JP2008513504A5 (https=) | ||
| JP2008513496A5 (https=) | ||
| JP2008513499A5 (https=) | ||
| JP6517928B2 (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| RU2006105717A (ru) | Производные пиперазина и их применение в качестве терапевтических агентов | |
| JP2008513515A5 (https=) | ||
| CN102292340B (zh) | 用作pde9 抑制剂的氨基-杂环类化合物 | |
| JP6505023B2 (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| CN102325753B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| JP2011523945A5 (https=) | ||
| WO2018043747A1 (ja) | 抗ｂ型肝炎ウイルス剤 | |
| JP2007500720A5 (https=) | ||
| KR20150118148A (ko) | Trk 저해 화합물 | |
| CN1152870A (zh) | 杂环化合物作为多巴胺d3配位体的用途 | |
| CA2597069A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| JP2008513514A5 (https=) | ||
| RU2006105716A (ru) | Производные пиридазина и их применение в качестве терапевтических средств | |
| JP5654467B2 (ja) | ４−アミノ−３−（イミダゾリル）−ピラゾロ［３，４−ｄ］ピリミジン | |
| EA032028B1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
| KR20170055531A (ko) | 에스지씨 자극제 | |
| EA031201B1 (ru) | Соединения имидазопиридазина | |
| WO2006125180B1 (en) | Piperazine derivatives and their uses as therapeutic agents |